Table 2.
Correlation between miR-216a-5p expression and clinicopathological characteristics of colorectal cancer patients
| Clinical parameter | MiR-216a-5p | P-value | ||
|---|---|---|---|---|
| Low (n=35) | High (n=35) | |||
| Gender | Male | 17 (42.5%) | 23 (57.5%) | 0.147 |
| Female | 18 (60.0%) | 12 (40.0%) | ||
| Age | ＜60 | 18 (50.0%) | 18 (50.0%) | 1.000 |
| ≥60 | 17 (50.0%) | 17 (50.0%) | ||
| Differentiation | Well+moderate | 13 (44.8%) | 16 (55.2%) | 0.467 |
| Poor+undifferentiated | 22 (53.7%) | 19 (46.3%) | ||
| Tumor size (cm) | ＜3 | 18 (46.2%) | 21 (53.8%) | 0.470 |
| ≥3 | 17 (54.8%) | 14 (45.2%) | ||
| T stage | T1 T2 | 10 (34.5%) | 19 (65.5%) | 0.029 |
| T3+T4 | 25 (61.0%) | 16 (39.0%) | ||
| Lymphatic metastasis | N0 | 9 (30.0%) | 21 (70.0%) | 0.014 |
| N1 | 21 (63.6%) | 12 (36.4%) | ||
| N2 | 5 (71.4%) | 2 (28.6%) | ||